The present invention relates to a new means for the treatment of focal ischemic cerebral infarction (ischemic stroke). It has been found that reduction of 2-antiplasmin leads to a significantly smaller focal cerebral infarct size. The invention therefore provides the use of compounds that reduce 2-antiplasmin concentration or activity in vivo, for the preparation of a therapeutical composition for the treatment of focal cerebral ischemic infarction (ischemic stroke).

 
Web www.patentalert.com

< Porous material formation by chemical vapor deposition onto colloidal crystal templates

< Regulation of human prostasin-like serine protease

> Strumpad and string array processing for musical instruments

> Enzymatic methods for modulating the levels of organic sulfur compounds in plants

~ 00208